Multiple myeloma in Saudi Arabia: Consensus of the Saudi lymphoma/myeloma group

Abstract

Multiple myeloma (MM) is a relatively uncommon cancer in Saudi Arabia. It is estimated that MM and lymphomas accounted for 9.6%-11% of cancer-related deaths in the Kingdom in 2014. However, published data on the characteristics and treatment patterns of, and outcomes for, MM patients in Saudi Arabia are scant. The Saudi Lymphoma/Myeloma held the 'Scientific Gap Analysis Advisory Board' meeting in Riyadh on January 26, 2018, which represented six Saudi specialized institutions, in order to discuss different aspects of MM management in Saudi Arabia and to reach a consensus statement in each aspect of MM in Saudi Arabia. This consensus meeting brought together a panel of Saudi experts in MM to share their views on current trends and practice in Saudi Arabia and how these compare with the global picture.